Southeast Hospital is a private, not-for-profit hospital located in Cape Girardeau, Missouri. Southeast Missouri Hospital first opened in 1928 and has grown into a regional medical complex serving over 600,000 people in 22 counties in Southeast Missouri and Southern Illinois.

During the past decade, Southeast Missouri Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 24 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeast Missouri Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 25 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "GOG Foundation" with 1 trials sponsored and "Gynecologic Oncology Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeast Missouri Hospital" #1 collaborator was "Cancer and Leukemia Group B" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Southeast Missouri Hospital" are "Recurrent Breast Carcinoma" (4 trials), "Stage IIIB Breast Cancer AJCC v7" (4 trials), "Stage IIIC Breast Cancer AJCC v7" (3 trials), "Stage IV Breast Cancer AJCC v6 and v7" (3 trials) and "Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11" (2 trials). Many other conditions were trialed in "Southeast Missouri Hospital" in a lesser frequency.

Most popular intervention types in "Southeast Missouri Hospital" are "Drug" (28 trials), "Other" (22 trials), "Biological" (15 trials), "Radiation" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Bevacizumab" (9 trials), "Quality-of-Life Assessment" (9 trials), "Paclitaxel" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Southeast Missouri Hospital" are 23 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Southeast Missouri Hospital". undefined are not yet recruiting, undefined are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Southeast Missouri Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Southeast Missouri Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Southeast Missouri Hospital has several departments that took part in Clinical trials: "Southeast Cancer Center" - 307 trials